NEW YORK, Sept. 06, 2017 -- Gainey McKenna & Egleston announces that it has voluntarily dismissed its action filed against Mallinckrodt Public Limited Company (“Mallinckrodt”) in the United States District Court for the Eastern District of Missouri and refiled its action in the United States District Court for the District of Columbia, Case No. 17-cv-01827. The action is still brought on behalf of the Company’s Employee Stock Purchase Plan (“ESPP”), against certain Defendants, to cover those persons who purchased or otherwise acquired Mallinckrodt stock between November 25, 2014 and January 18, 2017 (“Relevant Period”) in the ESPP. The action brings claims under § 11 of the Securities Act of 1933 as well as claims under state law for breach of fiduciary duty, non-disclosure and breach of contract.
If you wish to serve as lead plaintiff, you must move the United States District Court for the District of Columbia no later than September 22, 2017. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].


Bank of America's $72.5M Epstein Settlement: What You Need to Know
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations 



